Application of Radiomics-based AI Models in Predicting Clinical Outcome of Patients With Renal Cell Carcinoma After Surgical Treatment
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Renal Cell Carcinoma (Kidney Cancer). Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- China
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Application of Radiomics-based AI Models in Predicting Clinical Outcome of Patients With Renal Cell Carcinoma After Surgical Treatment (AI-Kidney-Prognosis)
Overview
This is a prospective observational cohort study (AI-Kidney-Prognosis), aiming to non-invasively predict the clinical outcomes in renal cell carcinoma patients after surgical treatment using radiomics-based AI models, thereby assisting clinical decision-making and personalized follow-up strategies.
Primary outcome measures
- Progression-free survival [Time frame: 1 year]
Eligibility criteria
Inclusion criteria
- Patients were treated for renal cell carcinoma in Wuhan Union Hospital from August 2025 to August 2026;
- Aged > 18 years old;
- At least one abdominal CT scan before treatment;
- Tissue biopsy pathological examination confirmed the diagnosis of renal cell carcinoma.
Exclusion criteria
- Poor image quality;
- Incomplete clinical data or loss of follow-up;
- Presence of another primary malignancy other than renal cell carcinoma;
- Unclear pathological diagnosis.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
China · 1 center
- Union Hospital，Tongji Medical College，Huazhong University of Science and Technology — Wuhan
Identifiers
NCT: NCT07118813 · 2025-0672